Treatment considerations in actinic keratosis
Author:
Affiliation:
1. Icahn School of Medicine at Mount Sinai Hospital; New York NY USA
Publisher
Wiley
Subject
Infectious Diseases,Dermatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/jdv.14152/fullpdf
Reference47 articles.
1. Management of actinic keratosis: a practical report and treatment algorithm from AKTeam™ expert clinicians;Dréno;J Eur Acad Dermatol Venereol,2014
2. The influence of painful sunburns and lifetime sun exposure on the risk of actinic keratoses, seborrheic warts, melanocytic nevi, atypical nevi, and skin cancer;Kennedy;J Invest Dermatol,2003
3. Relationship of p53 mutations to epidermal cell proliferation and apoptosis in human UV-induced skin carcinogenesis;Einspahr;Neoplasia,1999
4. Analysis of genes responding to ultraviolet B irradiation of HaCaT keratinocytes using a cDNA microarray;Lee;Br J Dermatol,2005
5. Frequent clones of p53-mutated keratinocytes in normal human skin;Jonason;Proc Natl Acad Sci U S A,1996
Cited by 33 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Safety and tolerability of tirbanibulin ointment 1% treatment on 100 cm2 of the face or scalp in patients with actinic keratosis: A phase 3 study;JAAD International;2024-12
2. Photographic scale for the characterization of actinic keratosis through reflectance confocal microscopy: a quantitative approach to cellular transformation;Frontiers in Medicine;2024-09-04
3. Topical Pharmacological Treatment of Actinic Keratoses: Focus on Tirbanibulin 1% Ointment;Dermatology Practical & Conceptual;2024-08-07
4. Combination therapy with imiquimod and 5-fluorouracil cream for the treatment of actinic keratoses, a prospective open-label nonrandomized uncontrolled pilot trial;Journal of the American Academy of Dermatology;2024-06
5. Pharmacokinetics, Safety, and Tolerability of a Single 5‐Day Treatment of Tirbanibulin Ointment 1% in 100 cm2: A Phase 1 Maximal‐Use Trial in Patients with Actinic Keratosis;Clinical Pharmacology in Drug Development;2024-01-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3